Myeloid derived suppressor cells are numerically, functionally and phenotypically different in patients with multiple myeloma

References

• Ramachandran IR, Martner A, Pisklakova A, et al. Myeloid- derived-suppressor cells as regulators of the immune system. Nat Rev Immunol 2009;9:162–174.
   PubMed Web of Science ®Google Scholar
• Mougiakakos D, Choudhury A, Lladser A, et al. Regulatory T cells in cancer. Adv Cancer Res 2010;107:57–117.
   PubMed Web of Science ®Google Scholar
• Teng MW, Ritchie DS, Neeson P, et al. Biology and clinical observations of regulatory T cells in cancer immunology. Curr Top Microbiol Immunol 2011;344:61–95.
   PubMed Web of Science ®Google Scholar
• Braga WM, Atanackovic D, Colleoni GW. The role of regulatory T cells and TH17 cells in multiple myeloma. Clin Dev Immunol 2012;2012:293479.
   PubMed Web of Science ®Google Scholar
• von Boehmer H, Daniel C. Therapeutic opportunities for manipulating T(Reg) cells in autoimmunity and cancer. Nat Rev Drug Discov 2013;12:51–63.
   PubMed Web of Science ®Google Scholar
• Favaloro J, Brown R, Aklilu E et al. Myeloma skews Treg and Th17 cell balance in favor of a suppressive state. Leuk Lymphoma 2013 Aug 28. [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• Marigo I, Dolcetti L, Serafini P, et al. Tumor-induced tolerance and immune suppression by myeloid derived suppressor cells. Immunol Rev 2008;222:162–179.
   PubMed Web of Science ®Google Scholar
• Gabrilovich DI, Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol 2009;9:162–174.
   PubMed Web of Science ®Google Scholar
• Rodriguez PC, Ernstoff MS, Hernandez C, et al. Arginase I-producing myeloid-derived suppressor cells in renal cell carcinoma are a subpopulation of activated granulocytes. Cancer Res 2009;69: 1553–1560.
   PubMed Web of Science ®Google Scholar
• Hoechst B, Ormandy LA, Ballmaier M, et al. A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4(+)CD25(+)Foxp3(+) T cells. Gastroenterology 2008;135:234–243.
   PubMed Web of Science ®Google Scholar
• Huang B, Pan PY, Li Q, et al. Gr-1 + CD115 + immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host. Cancer Res 2006;66:1123–1131.
   PubMed Web of Science ®Google Scholar
• Fujimura T, Ring S, Umansky V, et al. Regulatory T cells stimulate B7-H1 expression in myeloid-derived suppressor cells in ret melanomas. J Invest Dermatol 2012;132:1239–1246.
   PubMed Web of Science ®Google Scholar
• Liu Y, Zeng B, Zhang Z, et al. B7-H1 on myeloid-derived suppressor cells in immune suppression by a mouse model of ovarian cancer. Clin Immunol 2008;129:471–481.
   PubMed Web of Science ®Google Scholar
• Wilcox R, Feldman AL, Wada DA, et al. B7-H1 (PD-L1, CD274) suppresses host immunity in T-cell lymphoproliferative disorders. Blood 2009;114:2149–2158.
   PubMed Web of Science ®Google Scholar
• Poschke I, Mougiakakos D, Hansson J, et al. Immature immunosuppressive CD14 + HLA-DR-/low cells in melanoma patients are Stat3hi and overexpress CD80, CD83, and DC-sign. Cancer Res 2010;70:4335–4345.
   PubMed Web of Science ®Google Scholar
• Chen S, Akbar SM, Abe M, et al. Immunosuppressive functions of hepatic myeloid-derived suppressor cells of normal mice and in a murine model of chronic hepatitis B virus. Clin Exp Immunol 2011;166:134–142.
   PubMed Web of Science ®Google Scholar
• Cripps JG, Wang J, Maria A, et al. Type 1 T helper cells induce the accumulation of myeloid-derived suppressor cells in the inflamed Tgfb1 knockout mouse liver. Hepatology 2010;52:1350–1359.
   PubMed Web of Science ®Google Scholar
• Qin A, Cai W, Pan T, et al. Expansion of monocytic myeloid-derived suppressor cells dampens T cell function in HIV-1-seropositive individuals. J Virol 2013;87:1477–1490.
   PubMed Web of Science ®Google Scholar
• Vollbrecht T, Stirner R, Tufman A, et al. Chronic progressive HIV-1 infection is associated with elevated levels of myeloid-derived suppressor cells. AIDS 2012;26:F31–F37.
   PubMed Web of Science ®Google Scholar
• Zhang B, Wang Z, Wu L, et al. Circulating and tumor-infiltrating myeloid-derived suppressor cells in patients with colorectal carcinoma. PLoS One 2013;8:e57114.
   PubMed Web of Science ®Google Scholar
• Christiansson L, Soderlund S, Svensson E, et al. Increased level of myeloid-derived suppressor cells, programmed death receptor ligand 1/programmed death receptor 1, and soluble CD25 in Sokal high risk chronic myeloid leukemia. PLoS One 2013;8:e55818.
   PubMed Web of Science ®Google Scholar
• Gorgun GT, Whitehill G, Anderson JL, et al. Tumor-promoting immune-suppressive myeloid-derived suppressor cells in the multiple myeloma microenvironment in humans. Blood 2013;121:2975–2987.
   PubMed Web of Science ®Google Scholar
• Ramachandran IR, Martner A, Pisklakova A, et al. Myeloid-derived suppressor cells regulate growth of multiple myeloma by inhibiting T cells in bone marrow. J Immunol 2013;190:3815–3823.
   PubMed Web of Science ®Google Scholar
• Zhuang J, Zhang J, Lwin ST, et al. Osteoclasts in multiple myeloma are derived from Gr-1 + CD11b+ myeloid-derived suppressor cells. PLoS One 2012;7:e48871.
   PubMed Web of Science ®Google Scholar
• Waight JD, Hu Q, Miller A, et al. Tumor-derived G-CSF facilitates neoplastic growth through a granulocytic myeloid-derived suppressor cell-dependent mechanism. PLoS One 2011;6:e27690.
   PubMed Web of Science ®Google Scholar
• Dilek N, Poirier N, Usal C, et al. Control of transplant tolerance and intragraft regulatory T cell localization by myeloid-derived suppressor cells and CCL5. J Immunol 2012;188:4209–4216.
   PubMed Web of Science ®Google Scholar
• Dugast A, Haudebourg T, Coulon F, et al. Myeloid-derived suppressor cells accumulate in kidney allograft tolerance and specifically suppress effector T cell expansion. J Immunol 2008;180: 7898–7906.
   PubMed Web of Science ®Google Scholar
• Highfill SL, Rodriguez PC, Zhou Q, et al. Bone marrow myeloid-derived suppressor cells (MDSCs) inhibit graft-versus-host disease (GVHD) via an arginase-1-dependent mechanism that is up-regulated by interleukin-13. Blood 2010;116:5738–5747.
   PubMed Web of Science ®Google Scholar
• Wang Y, Gu X, Xiang J, et al. Myeloid-derived suppressor cells participate in preventing graft rejection. Clin Dev Immunol 2012;2012:731486.
   PubMedGoogle Scholar
• To LB, Levesque JP, Herbert KE. How I treat patients who mobilize hematopoietic stem cells poorly. Blood 2011;118:4530–4540.
   PubMed Web of Science ®Google Scholar
• Verschoor CP, Johnstone J, Millar J, et al. Blood CD33(+)HLA-DR(-) myeloid-derived suppressor cells are increased with age and a history of cancer. J Leukoc Biol 2013;93:633–637.
   Google Scholar
• Durie BGM, Harousseau J-L, Miguel JS, et al. International uniform response criteria for multiuple myeloma. Leukemia 2006; 30:1–7.
   Web of Science ®Google Scholar
• Kiavash Movahedi K, Guilliams, M, Van den Bossche J, et al. Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity. Blood 2008;111:4233–4244.
   PubMed Web of Science ®Google Scholar
• Lechner MG, Liebertz DJ, Epstein AL. Characterization of cytokine-induced myeloid-derived suppressor cells from normal human peripheral blood mononuclear cells. J Immunol 2010;185: 2273–2284.
   PubMed Web of Science ®Google Scholar